Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DX26FL475
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $14,348
Award facts
- Contract value 100% obligated
- $14,348.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a delivery order valued at $14,348.33 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This firm fixed-price delivery order, issued on October 31, 2025, represents one of numerous orders placed with DMS Pharmaceutical Group under its larger Indefinite Delivery Contract (IDC) established through the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The delivery order contains no set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group maintains SAM registration dating to 2001 and specializes in distributing comprehensive pharmaceutical products and medical consumables to federal agencies, with no identified subcontractor relationships on this award.
The underlying PPV-G GEN V contract, valued at $499,999,999 and awarded November 13, 2025, positions DMS Pharmaceutical Group as a regional prime vendor contractor within the broader $30.3 billion acquisition strategy designed to support recurring medical supply needs of Department of Defense healthcare facilities worldwide. The IDC spans a 30-month base period with three 30-month option periods through December 31, 2036, authorizing DLA to issue delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. DMS Pharmaceutical Group's product portfolio encompasses oncology treatments, immunosuppressants, emergency medications, specialty surgical products, and routine pharmaceuticals, positioning the company as a critical supplier within the federal pharmaceutical supply chain for military healthcare operations.
Quick answers
Who was awarded contract SPE2DX26FL475?
SPE2DX26FL475 was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on October 31, 2025.
How much is contract SPE2DX26FL475 worth?
The government has obligated $14,348 on SPE2DX26FL475.
Is contract SPE2DX26FL475 an order under another contract?
Yes. SPE2DX26FL475 is a delivery order under SPE2DX16D9414, an indefinite delivery contract.
Was contract SPE2DX26FL475 competed?
The extent of competition for SPE2DX26FL475 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award